166 related articles for article (PubMed ID: 31904393)
1. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
Zhang S; Wang J; Song N; Xie J; Jiang H
Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitylase OTUD3 prevents Parkinson's disease through stabilizing iron regulatory protein 2.
Jia F; Li H; Jiao Q; Li C; Fu L; Cui C; Jiang H; Zhang L
Cell Death Dis; 2022 Apr; 13(4):418. PubMed ID: 35490179
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J
Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
[TBL] [Abstract][Full Text] [Related]
7. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
8. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
Youdim MB
J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050
[TBL] [Abstract][Full Text] [Related]
9. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
10. Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.
Deplazes J; Schöbel K; Hochstrasser H; Bauer P; Walter U; Behnke S; Spiegel J; Becker G; Riess O; Berg D
J Neural Transm (Vienna); 2004 Apr; 111(4):515-21. PubMed ID: 15057521
[TBL] [Abstract][Full Text] [Related]
11. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
Jia W; Xu H; Du X; Jiang H; Xie J
Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
[TBL] [Abstract][Full Text] [Related]
12. [Increased DMT1 expression and iron content in MPTP-treated C57BL/6 mice].
Jiang H; Qian ZM; Xie JX
Sheng Li Xue Bao; 2003 Oct; 55(5):571-6. PubMed ID: 14566406
[TBL] [Abstract][Full Text] [Related]
13. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
[TBL] [Abstract][Full Text] [Related]
14. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
Song N; Wang J; Jiang H; Xie J
Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
[TBL] [Abstract][Full Text] [Related]
15. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.
Zumbrennen-Bullough KB; Becker L; Garrett L; Hölter SM; Calzada-Wack J; Mossbrugger I; Quintanilla-Fend L; Racz I; Rathkolb B; Klopstock T; Wurst W; Zimmer A; Wolf E; Fuchs H; Gailus-Durner V; de Angelis MH; Romney SJ; Leibold EA
PLoS One; 2014; 9(6):e98072. PubMed ID: 24896637
[TBL] [Abstract][Full Text] [Related]
16. Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx.
Song N; Jiang H; Wang J; Xie JX
J Neurosci Res; 2007 Nov; 85(14):3118-26. PubMed ID: 17663481
[TBL] [Abstract][Full Text] [Related]
17. Irp2 Knockout Causes Osteoporosis by Inhibition of Bone Remodeling.
Zhou Y; Yang Y; Liu Y; Chang H; Liu K; Zhang X; Chang Y
Calcif Tissue Int; 2019 Jan; 104(1):70-78. PubMed ID: 30191282
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of iron-induced oxidative insults in neurodegeneration.
Asano T; Koike M; Sakata S; Takeda Y; Nakagawa T; Hatano T; Ohashi S; Funayama M; Yoshimi K; Asanuma M; Toyokuni S; Mochizuki H; Uchiyama Y; Hattori N; Iwai K
Neurosci Lett; 2015 Feb; 588():29-35. PubMed ID: 25549542
[TBL] [Abstract][Full Text] [Related]
19. Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.
Kaur D; Rajagopalan S; Andersen JK
Brain Res; 2009 Nov; 1297():17-22. PubMed ID: 19699718
[TBL] [Abstract][Full Text] [Related]
20. Iron regulatory protein 2 deficiency may correlate with insulin resistance.
Zhou Y; Wu W; Xu Z; Liu Y; Chang H; Yu P; Zhang X; Yang Y; Liu K; Chang Y
Biochem Biophys Res Commun; 2019 Mar; 510(2):191-197. PubMed ID: 30685084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
